BlackRock Institutional Trust’s Impax Laboratories, Inc. IPXL Stock Holding History

BlackRock Institutional Trust’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$24.6M	Buy	1,859,829 +100,708	+6%	+$1.72M	﹤0.01%	1820
2016 Q3	$41.7M	Buy	1,759,121 +28,933	+2%	+$778K	0.01%	1401
2016 Q2	$49.9M	Buy	1,730,188 +8,364	+0.5%	+$273K	0.01%	1245
2016 Q1	$55.1M	Buy	1,721,824 +40,458	+2%	+$1.42M	0.01%	1157
2015 Q4	$71.9M	Buy	1,681,366 +32,295	+2%	+$1.29M	0.01%	1025
2015 Q3	$58.1M	Sell	1,649,071 -32,372	-2%	-$1.46M	0.01%	1152
2015 Q2	$77.2M	Sell	1,681,443 -125,712	-7%	-$5.97M	0.01%	1054
2015 Q1	$84.7M	Buy	1,807,155 +1,831	+0.1%	+$72.9K	0.01%	1018
2014 Q4	$57.2M	Sell	1,805,324 -31,138	-2%	-$911K	0.01%	1205
2014 Q3	$43.5M	Sell	1,836,462 -55,804	-3%	-$1.43M	0.01%	1347
2014 Q2	$56.7M	Sell	1,892,266 -57,819	-3%	-$1.56M	0.01%	1233
2014 Q1	$51.5M	Buy	1,950,085 +60,069	+3%	+$1.5M	0.01%	1253
2013 Q4	$47.5M	Sell	1,890,016 -384,271	-17%	-$8.57M	0.01%	1292
2013 Q3	$46.6M	Buy	2,274,287 +405,312	+22%	+$8.37M	0.01%	1248
2013 Q2	$37.3M	Buy	+1,868,975	New	+$33.2M	0.01%	1348

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

BlackRock Institutional Trust's IPXL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Impax Laboratories, Inc. (IPXL) stake by 5.7% in Q4 2016, buying an estimated $1.72M and bringing the position to 1,859,829 shares worth $24.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

BlackRock Institutional Trust first reported a position in IPXL in Q2 2013 and has held it in 15 quarters since. The position peaked at $84.7M in Q1 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

BlackRock Institutional Trust held 1,859,829 shares of Impax Laboratories, Inc. worth $24.6M as of Q4 2016.
BlackRock Institutional Trust bought 100,708 Impax Laboratories, Inc. shares in Q4 2016, an estimated $1.72M.
Impax Laboratories, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1820 holding.
BlackRock Institutional Trust first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Impax Laboratories, Inc. position peaked at $84.7M in Q1 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.